Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of finerenone in type 2 diabetes mellitus with diabetic kidney disease
2015-000950-39Phase 3Completed
- Sponsor
- Bayer
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic glomerulosclerosis and cardiac morbidity comparing Finerenone + standard of care with Placebo + standard of care (2 arms). Started Jun 2015; status: completed.
02
Drugs
finerenone
03
Conditions
diabetic glomerulosclerosiscardiac morbidity
Beyond the preview
Go deeper on 2015-000950-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000950-39.